GLP-1 medications are marketed to help you lose weight, but one may be better at it than the rest, according to a new meta-analysis from the University of Georgia.
* **Most Effective:** **Tirzepatide** (marketed as Zepbound for weight loss) was the most effective, helping patients lose **more than 20%** of their starting body weight. Researchers attribute this to its dual mechanism, mimicking both GLP-1 and GIP gut hormones.
* **Moderate Efficacy:** **Semaglutide** (Wegovy) led to a **15%** reduction in body weight. An analysis of a 50 mg oral version showed it was not as effective as tirzepatide, though it performed almost as well as the injectable semaglutide.
* **Least Effective:** **Liraglutide** (Saxenda) was the least effective, resulting in an **8%** weight reduction. It also requires daily injections, whereas tirzepatide and semaglutide are weekly.
1 Comment
* **Most Effective:** **Tirzepatide** (marketed as Zepbound for weight loss) was the most effective, helping patients lose **more than 20%** of their starting body weight. Researchers attribute this to its dual mechanism, mimicking both GLP-1 and GIP gut hormones.
* **Moderate Efficacy:** **Semaglutide** (Wegovy) led to a **15%** reduction in body weight. An analysis of a 50 mg oral version showed it was not as effective as tirzepatide, though it performed almost as well as the injectable semaglutide.
* **Least Effective:** **Liraglutide** (Saxenda) was the least effective, resulting in an **8%** weight reduction. It also requires daily injections, whereas tirzepatide and semaglutide are weekly.